C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor

Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/2001
11/27/2001	CA2074837C Methods of producing hybrid g protein-coupled receptors
11/27/2001	CA2063511C Method for producing human serum albumin
11/27/2001	CA2021912C Erythropoietin (epo) peptides and antibodies directed against these
11/27/2001	CA1341322C Interleukin-1 inhibitors
11/26/2001	CA2346163A1 Complex for transferring an anionic substance of interest into a cell
11/26/2001	CA2316405A1 Modulation of inflammation by protease products
11/24/2001	CA2309235A1 Fusion polypeptides
11/22/2001	WO2001088533A2 Lipid uptake assays
11/22/2001	WO2001088532A2 Improved assay techniques using nematode worms
11/22/2001	WO2001088511A1 Grating optical waveguide structure for multi-analyte determinations and the use thereof
11/22/2001	WO2001088203A1 Cloning of rhadinovirus genome and methods for its use
11/22/2001	WO2001088199A2 Identification and modulationof of a t helper-1 and t helper-2 cells
11/22/2001	WO2001088198A1 Antisense modulation of tert expression
11/22/2001	WO2001088197A2 Methods and compositions for interaction trap assays
11/22/2001	WO2001088196A2 Sequence based screening
11/22/2001	WO2001088192A2 A method for generating hypermutable organisms
11/22/2001	WO2001088190A2 Poly-primed amplification of nucleic acid sequences
11/22/2001	WO2001088188A2 Method for examining ischemic conditions
11/22/2001	WO2001088185A2 A filter element for use in separation of biomaterials from solid contaminants
11/22/2001	WO2001088173A2 Methods for the enzymatic assembly of polynucleotides and identification of polynucleotides having desired characteristics
11/22/2001	WO2001088171A1 Method for introducing a nucleic acid into a cell (transfection) by means of calcium phosphate, and transfected cell
11/22/2001	WO2001088170A2 Plants with enhanced starch and methods for obtaining them
11/22/2001	WO2001088169A2 Method for producing carotenoid compounds in plants
11/22/2001	WO2001088168A2 Mapping molecular interactions in plants with protein fragments complementation assays
11/22/2001	WO2001088167A2 Spike tissue-specific promoter
11/22/2001	WO2001088166A2 Insect resistant transgenic plants expressing biotin-binding protein gene
11/22/2001	WO2001088165A1 Nucleotide sequences coding for signal transduction components involved in plant pathogen defence
11/22/2001	WO2001088164A1 Inducible elimination of dna sequences in plants
11/22/2001	WO2001088163A1 Method for producing recombinant expansins
11/22/2001	WO2001088162A2 Methods and vectors for generating antibodies in avian species and uses therefor
11/22/2001	WO2001088160A2 Vectors for dna delivery
11/22/2001	WO2001088159A2 Cd28 synthebody for the modulation of immune responses
11/22/2001	WO2001088158A1 A novel polypeptide- human triose-phosphate isomerase 10 and the polynucleotide encoding said polypeptide
11/22/2001	WO2001088157A2 Treatment methods using 17906 and uses therefor
11/22/2001	WO2001088156A2 33428, a human metalloprotease family member and uses thereof
11/22/2001	WO2001088155A2 33428, a human metalloprotease family member and uses thereof
11/22/2001	WO2001088154A1 Microglobulin transcription human regulation factor 17
11/22/2001	WO2001088153A1 Novel polypeptide...a nadh ubiquinone oxidoreductase 14 and polynucleotide encoding it
11/22/2001	WO2001088152A1 Novel polypeptide--- a human ubiquitin conjugating enzyme 13 and polynucleotide encoding it
11/22/2001	WO2001088151A1 Novel polypeptide - a human microglobulin transcriptional control factor 30 and polynucleotide encoding it
11/22/2001	WO2001088150A1 Probiotic lactic acid bacteria, unable to utilize lactose
11/22/2001	WO2001088148A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
11/22/2001	WO2001088147A1 A novel polypeptide, a human tyrosine kinase 14 and the polynucleotide encoding the polypeptide
11/22/2001	WO2001088146A1 A novel polypeptide, a human alkylation-dna-protein cysteine methyltransferase 11 and the polynucleotide encoding the polypeptide
11/22/2001	WO2001088145A1 Recombinant microorganism expressing polyhydroxyalkanoate biosynthesis enzyme and intracellular pha depolymerase
11/22/2001	WO2001088144A1 Transformant and process for producing polyester by using the same
11/22/2001	WO2001088141A2 Synthetic gagpol genes and their uses
11/22/2001	WO2001088140A1 Polypeptide involved in cell adhesion and phagocytosis and its use in treatment
11/22/2001	WO2001088139A2 Proteins interacting with a sucrose transporter
11/22/2001	WO2001088138A1 Humanised antibodies to the epidermal growth factor receptor
11/22/2001	WO2001088137A2 Human myd88 adapter-like protein and functional fragments thereof
11/22/2001	WO2001088136A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
11/22/2001	WO2001088135A2 G-protein coupled receptor proteins and nucleic acids encoding same
11/22/2001	WO2001088134A2 Novel human lipocalin homologs and polynucleotides encoding the same
11/22/2001	WO2001088133A2 Human semaphorin homologs and polynucleotides encoding the same
11/22/2001	WO2001088132A2 Rabies virus-specific neutralizing human monoclonal antibodies and nucleic acids and related methods
11/22/2001	WO2001088131A1 Regulation of mt1-mmp activity
11/22/2001	WO2001088130A1 Molecular cloning and identification of a human leukotriene-like receptor ltxr
11/22/2001	WO2001088129A1 Anti-angiogenic polypeptides
11/22/2001	WO2001088128A1 Ssa-56kda polypeptide and its fragments and polynucleotides encoding said polypeptides and therapeutic uses
11/22/2001	WO2001088127A2 Regulation of human follicle stimulating hormone-like g protein-coupled receptor
11/22/2001	WO2001088126A2 REGULATION OF HUMAN α1Α ADRENERGIC RECEPTOR-LIKE G PROTEIN-COUPLED RECEPTOR
11/22/2001	WO2001088125A1 MUTATION IN THE β2 NICOTINIC ACETYLCHOLINE RECEPTOR SUBUNIT ASSOCIATED WITH NOCTURNAL FRONTAL LOBE EPILEPSY
11/22/2001	WO2001088124A2 Method and reagent for the inhibition of erg
11/22/2001	WO2001088123A1 Ligands specific for an isoform of the prion protein
11/22/2001	WO2001088121A1 Vector constructs
11/22/2001	WO2001088120A1 Gene associating open-angle glaucoma including normal ocular tension glaucoma
11/22/2001	WO2001088119A1 Novel g protein-coupled receptor protein and dna thereof
11/22/2001	WO2001088118A1 Novel motor proteins and methods for their use
11/22/2001	WO2001088117A2 In vitro fucosylation recombinant glycopeptides
11/22/2001	WO2001088116A2 Method of modulating activation of lymphocytes via modulation of pituitary tumor transforming gene, related screeining methods
11/22/2001	WO2001088114A2 Gene expression system
11/22/2001	WO2001088110A1 Directed evolution of oxidase enzymes
11/22/2001	WO2001088109A2 Model for neurodegenerative disease
11/22/2001	WO2001088108A1 Neuronal serine-threonine protein kinase
11/22/2001	WO2001088107A2 Alpha-amylase variants with altered 1,6-activity
11/22/2001	WO2001088106A2 Novel deoxyribonucleside kinase enzyme multi-substrate variants
11/22/2001	WO2001088104A2 Neural progenitor cell populations
11/22/2001	WO2001088103A2 Compositions and methods for tissue dedifferentiation and regeneration
11/22/2001	WO2001088101A2 CELL LINE FOR THE EXPRESSION OF AN α2δ2 CALCIUM CHANNEL SUBUNIT
11/22/2001	WO2001088097A1 Immune potentiating compositions
11/22/2001	WO2001088090A2 Cng3b: a novel cyclic nucleotide-gated cation channel
11/22/2001	WO2001088089A2 Single copy genomic hybridization probes and method of generating same
11/22/2001	WO2001088085A2 Novel bee venom polypeptides and methods of use thereof
11/22/2001	WO2001088017A1 Polypeptide derivatives and nucleic acid carriers containing the same
11/22/2001	WO2001087982A2 Immunotoxin fusion proteins and means for expression thereof
11/22/2001	WO2001087981A2 Human monoclonal antibody against a costimulatory signal transduction molecule ailim and pharmaceutical use thereof
11/22/2001	WO2001087980A2 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof
11/22/2001	WO2001087979A2 Methods and compositions of matter concerning april/g70, bcma, blys/agp-3, and taci
11/22/2001	WO2001087977A2 Methods and compositions of matter concerning april/g70, bcma, blys/agp-3, and taci
11/22/2001	WO2001087976A2 Gpcr 4-helix and 5-helix bundles
11/22/2001	WO2001087972A1 A novel polypeptide-human tumor-inhibiting factor dpc4 protein 9 and a polynucleotide encoding the same
11/22/2001	WO2001087971A1 A novel polypeptide, human ribosomal protein s18-14 and the polynucleotide encoding thereof
11/22/2001	WO2001087970A1 A novel polypeptide, human tyrosinase 12 and the polynucleotide encoding thereof
11/22/2001	WO2001087969A1 A novel polypeptide, human sox9 protein 13 and the polynucleotide encoding thereof
11/22/2001	WO2001087968A1 A novel polypeptide -human ribosomal protein s4-36 and a polynucleotide encoding the same
11/22/2001	WO2001087967A1 A novel polypeptide -human ribosomal protein s18-26 and a polynucleotide encoding the same
11/22/2001	WO2001087966A1 A new polypeptide-human pax protein 22 and the polynucleotide encoding it
11/22/2001	WO2001087965A1 A novel polypeptide -human synapse channel-assocaited protein 15 and a polynucleotide encoding the same
11/22/2001	WO2001087964A1 A new polypeptide- human gap connexin 15 and the polynucleotide encoding it

1 ... 2936 2937 2938 2939 2940 2941 2942 2943 2944 2945 2946 2947 2948 2949 2950 2951 2952 2953 2954 2955 2956 ... 4023